公开(公告)号：US20140080886A1

公开(公告)日：2014-03-20

申请号：US14029333

申请日：2013-09-17

Applicant: AbbVie Inc.

Inventor： Tami J. Pilot-Matias ,  Preethi Krishnan ,  Warren M. Kati ,  Christine A. Collins ,  Neeta C. Mistry ,  Clarence J. Maring ,  David A. DeGoey ,  John K. Pratt ,  Dachun Liu ,  Rolf Wagner

IPC: A61K31/4025 ,  A61K45/06

CPC classification number: A61K31/4025 ,  A61K31/401 ,  A61K45/06 ,  A61K2300/00

Abstract: Pan-genotypic HCV inhibitors are described. This invention also relates to methods of using these inhibitors to treat HCV infection.

公开(公告)号：US09249138B2

公开(公告)日：2016-02-02

申请号：US14017901

申请日：2013-09-04

Applicant: ABBVIE INC.

Inventor： David A. Degoey ,  Pamela L. Donner ,  Warren M. Kati ,  Charles W. Hutchins ,  Allan C. Krueger ,  John T. Randolph ,  Christopher E. Motter ,  Preethi Krishnan ,  Neeta C. Mistry ,  Tami J. Pilot-Matias ,  Sachin V. Patel ,  Xiaoyan Li ,  Todd N. Soltwedel ,  Lissa T. Nelson

IPC: C07D239/48 ,  C07D471/04

CPC classification number: C07D471/04 ,  C07D239/48

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.